Here are four things to know about the partnership.
1. Accuryn is a urinary catheter that also functions as a diagnostic tool, delivering automated, real-time actionable data on urine output, core body temperature and intra-abdominal pressure, among other measurements.
2. Through the deal, Medline holds long-term exclusivity for the marketing and distribution of Accuryn in North America.
3. Medline will present the technology to intensivists and critical care nurses at the Society of Critical Care Medicine Annual Congress on Jan. 21 to Jan. 25 in Honolulu, according to David Greenberg, executive vice president of strategy and group president at Medline.
4. Accuryn holds market clearance from the Food and Drug Administration and is available for sale in the U.S.
More articles on supply chain:
Mobile supply chain solutions market to grow 13.2% annually through 2020
FDA approves Synergy’s drug for chronic idiopathic constipation
J&J’s Ethicon Endo-Surgery to acquire Megadyne Medical Products
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
